203 related articles for article (PubMed ID: 12853703)
1. Expression and function of CD28 on Epstein-Barr virus-positive B cell lines and AIDS-associated non-Hodgkin's lymphoma cell lines.
Widney D; Boscardin WJ; Kasravi A; Martínez-Maza O
Tumour Biol; 2003; 24(2):82-93. PubMed ID: 12853703
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of B7 molecules by the Epstein-Barr virus enhances susceptibility to lysis by a human NK-like cell line.
Montel AH; Morse PA; Brahmi Z
Cell Immunol; 1995 Jan; 160(1):104-14. PubMed ID: 7531116
[TBL] [Abstract][Full Text] [Related]
3. Distinct regulation of T-cell death by CD28 depending on both its aggregation and T-cell receptor triggering: a role for Fas-FasL.
Collette Y; Benziane A; Razanajaona D; Olive D
Blood; 1998 Aug; 92(4):1350-63. PubMed ID: 9694724
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
Makrigiannis AP; Musgrave BL; Hoskin DW
J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
[TBL] [Abstract][Full Text] [Related]
5. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
Moosig F; Csernok E; Wang G; Gross WL
Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
[TBL] [Abstract][Full Text] [Related]
6. A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.
Behar SM; Porcelli SA; Beckman EM; Brenner MB
J Exp Med; 1995 Dec; 182(6):2007-18. PubMed ID: 7500046
[TBL] [Abstract][Full Text] [Related]
7. New insights into the functionality of a virion-anchored host cell membrane protein: CD28 versus HIV type 1.
Giguère JF; Paquette JS; Bounou S; Cantin R; Tremblay MJ
J Immunol; 2002 Sep; 169(5):2762-71. PubMed ID: 12193751
[TBL] [Abstract][Full Text] [Related]
8. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines.
Delabie J; Ceuppens JL; Vandenberghe P; de Boer M; Coorevits L; De Wolf-Peeters C
Blood; 1993 Nov; 82(9):2845-52. PubMed ID: 7693051
[TBL] [Abstract][Full Text] [Related]
9. Reduced antigen-presenting function of human Epstein-Barr virus (EBV)-B cells and monocytes after UVB radiation is accompanied by decreased expression of B7, intercellular adhesion molecule-1 (ICAM-1) and LFA-3.
Kremer IB; Bos JD; Teunissen BM
Clin Exp Immunol; 1995 Sep; 101(3):461-7. PubMed ID: 7545094
[TBL] [Abstract][Full Text] [Related]
10. Intercellular adhesion molecule 1 is critical for activation of CD28-deficient T cells.
Gaglia JL; Greenfield EA; Mattoo A; Sharpe AH; Freeman GJ; Kuchroo VK
J Immunol; 2000 Dec; 165(11):6091-8. PubMed ID: 11086041
[TBL] [Abstract][Full Text] [Related]
11. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28.
Ryan M; McCarthy L; Rappuoli R; Mahon BP; Mills KH
Int Immunol; 1998 May; 10(5):651-62. PubMed ID: 9645613
[TBL] [Abstract][Full Text] [Related]
12. Differential down-regulation of CD28 by B7-1 and B7-2 engagement.
Eck SC; Chang D; Wells AD; Turka LA
Transplantation; 1997 Nov; 64(10):1497-9. PubMed ID: 9392322
[TBL] [Abstract][Full Text] [Related]
13. Malignant plasma cell lines express a functional CD28 molecule.
Zhang XG; Olive D; Devos J; Rebouissou C; Ghiotto-Ragueneau M; Ferlin M; Klein B
Leukemia; 1998 Apr; 12(4):610-8. PubMed ID: 9557621
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.
Hathcock KS; Laszlo G; Pucillo C; Linsley P; Hodes RJ
J Exp Med; 1994 Aug; 180(2):631-40. PubMed ID: 7519245
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
[TBL] [Abstract][Full Text] [Related]
16. T cell-mediated elimination of B7.2 transgenic B cells.
Fournier S; Rathmell JC; Goodnow CC; Allison JP
Immunity; 1997 Mar; 6(3):327-39. PubMed ID: 9075933
[TBL] [Abstract][Full Text] [Related]
17. Expression of B7-2 (CD86) molecules by Reed-Sternberg cells of Hodgkin's disease.
Van Gool SW; Delabie J; Vandenberghe P; Coorevits L; De Wolf-Peeters C; Ceuppens JL
Leukemia; 1997 Jun; 11(6):846-51. PubMed ID: 9177439
[TBL] [Abstract][Full Text] [Related]
18. A theoretical framework for quantitative analysis of the molecular basis of costimulation.
Jansson A; Barnes E; Klenerman P; Harlén M; Sørensen P; Davis SJ; Nilsson P
J Immunol; 2005 Aug; 175(3):1575-85. PubMed ID: 16034096
[TBL] [Abstract][Full Text] [Related]
19. In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus.
Denfeld RW; Kind P; Sontheimer RD; Schöpf E; Simon JC
Arthritis Rheum; 1997 May; 40(5):814-21. PubMed ID: 9153541
[TBL] [Abstract][Full Text] [Related]
20. CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo.
Tang Q; Smith JA; Szot GL; Zhou P; Alegre ML; Henriksen KJ; Thompson CB; Bluestone JA
J Immunol; 2003 Feb; 170(3):1510-6. PubMed ID: 12538715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
